Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients.
Ali SM, Chen P, Sheikh S, Ahmad A, Ahmad M, Paithankar M, Desai B, Patel P, Khan M, Chaturvedi A, Patel R, Panchal DT, Shah K, Chavda V, Saboo BD, Patel A, Ahmad I.
Ali SM, et al. Among authors: ahmad i, ahmad m, ahmad a.
Drug Res (Stuttg). 2021 Jul;71(6):302-306. doi: 10.1055/a-1388-5415. Epub 2021 Mar 8.
Drug Res (Stuttg). 2021.
PMID: 33684953
Clinical Trial.